Clinical impact of clonal hematopoiesis in patients with lymphoma undergoing ASCT: a national population-based cohort study-Reference-Cited by-同舟云学术

Clinical impact of clonal hematopoiesis in patients with lymphoma undergoing ASCT: a national population-based cohort study

Published:2020-03-20 Issue:12 Volume:34 Page:3256-3268
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Husby Simon,Favero Francesco^ORCID,Nielsen Christian,Sørensen Betina S.,Bæch John,Grell Kathrine,Hansen Jakob W.,Rodriguez-Gonzalez Francisco G.,Haastrup Eva K.,Fischer-Nielsen Anne,Andersen Pernille,Arboe Bente,Sækmose Susanne G.,Hansen Per B.,Christiansen Ilse,Clasen-Linde Erik,Meldgaard Lene,Ebbesen Lene H.,Segel Erik K.,Josefsson Pär,Thorsgaard Michael,El-Galaly Tarec C.,Brown Peter,Weischenfeldt Joachim,Larsen Thomas S.,Grønbæk Kirsten

Funder

Region Hovedstaden

Novo Nordisk Fonden

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-020-0795-z.pdf

Reference27 articles.

1. Philip T, Guglielmi C, Hagenbeek A, Somers R, Van der Lelie H, Bron D, et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin’s lymphoma. N Engl J Med. 1995;333:1540–5.

2. Horning SJ, Chao NJ, Negrin RS, Hoppe RT, Long GD, Hu WW, et al. High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin’s disease: analysis of the Stanford University results and prognostic indices. Blood. 1997;89:801–13.